Back to top
more

Medtronic (MDT)

(Delayed Data from NYSE)

$82.84 USD

82.84
4,217,829

+0.08 (0.10%)

Updated May 10, 2024 04:00 PM ET

After-Market: $82.79 -0.05 (-0.06%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (100 out of 251)

Industry: Medical - Products

Better trading starts here.

Zacks News

Moumi Mondal headshot

Here's How Medtronic (MDT) Is Placed Ahead of Q4 Earnings

Medtronic's (MDT) rapid cadence of new product approvals is a strong foundation for future growth. However, the company also navigates some macroeconomic challenges.

Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates

Apyx (APYX) delivered earnings and revenue surprises of -22.22% and 6.27%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

National Vision (EYE) Q1 Earnings Top Estimates

National Vision (EYE) delivered earnings and revenue surprises of 7.14% and 2.68%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Bio-Rad Laboratories (BIO) Q1 Earnings Surpass Estimates

Bio-Rad (BIO) delivered earnings and revenue surprises of 12.25% and 0.23%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Medtronic (MDT) Rises Yet Lags Behind Market: Some Facts Worth Knowing

The latest trading day saw Medtronic (MDT) settling at $81.76, representing a +0.09% change from its previous close.

Medtronic PLC (MDT) is Attracting Investor Attention: Here is What You Should Know

Recently, Zacks.com users have been paying close attention to Medtronic (MDT). This makes it worthwhile to examine what the stock has in store.

Medtronic (MDT) Rises Higher Than Market: Key Facts

Medtronic (MDT) closed at $80.86 in the latest trading session, marking a +1.4% move from the prior day.

Medtronic PLC (MDT) Is a Trending Stock: Facts to Know Before Betting on It

Zacks.com users have recently been watching Medtronic (MDT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Medtronic (MDT) Laps the Stock Market: Here's Why

Medtronic (MDT) reachead $80.57 at the closing of the latest trading day, reflecting a +1.37% change compared to its last close.

Here's Why You Should Retain Medtronic (MDT) Stock for Now

Investors continue to be optimistic about Medtronic (MDT) due to the strength of its Neurosurgery and Cardiovascular portfolios.

The Zacks Analyst Blog Highlights Mastercard, Netflix, Coca-Cola, Berkshire Hathaway and Medtronic

Mastercard, Netflix, Coca-Cola, Berkshire Hathaway and Medtronic are included in this Analyst Blog.

Medtronic (MDT) Stock Sinks As Market Gains: What You Should Know

Medtronic (MDT) concluded the recent trading session at $79.35, signifying a -1.1% move from its prior day's close.

Sheraz Mian headshot

Q1 Earnings Scorecard and Analyst Reports for Mastercard, Netflix & Coca-Cola

Today's Research Daily features a real-time update on the Q1 earnings season and new research reports Mastercard (MA), Netflix (NFLX) and Coke (KO) and others.

Medtronic PLC (MDT) is Attracting Investor Attention: Here is What You Should Know

Zacks.com users have recently been watching Medtronic (MDT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Medtronic's (MDT) Sphere-360 PFA Study Outcome Favorable

Medtronic's (MDT) Sphere-360 catheter is designed to simplify the atrial fibrillation process while increasing efficiency and giving long-lasting lesions.

Medtronic (MDT) Falls More Steeply Than Broader Market: What Investors Need to Know

Medtronic (MDT) reachead $82.33 at the closing of the latest trading day, reflecting a -1.75% change compared to its last close.

Medtronic (MDT) Registers a Bigger Fall Than the Market: Important Facts to Note

In the closing of the recent trading day, Medtronic (MDT) stood at $83.92, denoting a -1.27% change from the preceding trading day.

Medtronic's (MDT) Newest Evolut TAVR System Gets FDA Approval

Medtronic (MDT) announces the FDA approval of the newest-generation Evolut TAVR system for the treatment of symptomatic severe aortic stenosis.

National Vision (EYE) Down 4.1% Since Last Earnings Report: Can It Rebound?

National Vision (EYE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Abbott (ABT) Expands in Canada With First Eterna SCS Use

Abbott's (ABT) Eterna SCS system reduces pain without causing discomfort. It leverages the BurstDR stimulation technology.

Medtronic (MDT) Down 2.2% Since Last Earnings Report: Can It Rebound?

Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Here's Why You Should Retain Medtronic (MDT) Stock for Now

Investors continue to be optimistic about Medtronic (MDT) on the strength of the Neurosurgery and Cardiovascular and Neurosurgery portfolios.

Medtronic's (MDT) MiniMed 780G System Study Data Favorable

Medtronic's (MDT) data from a recent study indicate that the MiniMed 780G system exceeds international targets for TIR and even brings patients closer to euglycemia.

The Zacks Analyst Blog Highlights Eli Lilly, The Procter & Gamble, Morgan Stanley, AT&T and Medtronic

Eli Lilly, The Procter & Gamble, Morgan Stanley, AT&T and Medtronic are part of the Zacks top Analyst Blog.